Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
The role of the pathologist in guiding therapy
- Type: Specialty Session
- Presentations: 5
- Moderators:K. Kerr
- Coordinates: 5/06/2017, 11:00 - 12:30, Room A
-
+
Conventional therapy for lung cancer
11:00 - 11:20 | Author(s): M.S. Tsao
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Targeted therapy for lung cancer
11:20 - 11:40 | Author(s): S. Lantuejoul
- Abstract
No abstract available for this presentation
-
+
Immunomodulatory therapy for lung cancer
11:40 - 12:00 | Author(s): F.R. Hirsch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Therapy for mesothelioma and other thoracic malignancies
12:00 - 12:20 | Author(s): A.G. Nicholson
- Abstract
No abstract available for this presentation
-
+
Questions and Answers / Panel Discussion
12:20 - 12:30
- Abstract
No abstract available for this presentation
-
+
Epidemiology and innovations in biomarker development
- Type: Poster Discussion session
- Presentations: 12
- Moderators:P. Boffetta
- Coordinates: 5/06/2017, 16:45 - 17:45, Room W
-
+
LBA3 - Correlation between clinical outcomes of patients treated within the tailor trial and next-generation sequencing (NGS) results: Analysis of genes associated to KRAS mutations
16:45 - 16:45 | Author(s): M. Ganzinelli
- Abstract
Loading... -
+
95PD - Diagnostic EGFR testing with ctDNA versus tumour in patients with advanced non-small cell lung cancer (NSCLC): The Royal Marsden experience
16:45 - 16:45 | Author(s): R. Kumar
- Abstract
Loading... -
+
Invited Discussant LBA3 and 95PD
16:45 - 17:00 | Author(s): S. Lantuejoul
- Abstract
No abstract available for this presentation
-
+
Discussion
17:00 - 17:05
- Abstract
No abstract available for this presentation
-
+
30PD_PR - Circulating immune-profile as predictor of outcome in NSCLC patients treated with nivolumab
17:05 - 17:05 | Author(s): M. Tiseo
- Abstract
Loading... -
+
96PD_PR - Evaluation of non-classical response by immune-modified RECIST and efficacy of atezolizumab beyond disease progression in advanced NSCLC: Results from the randomized Phase II study POPLAR
17:05 - 17:05 | Author(s): A. Artal-Cortes
- Abstract
Loading... -
+
Invited Discussant 30PD_PR and 96PD_PR
17:05 - 17:20 | Author(s): R..A. Stahel
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:20 - 17:25
- Abstract
No abstract available for this presentation
-
+
17PD - Patterns of lung cancer metastasis in the US population
17:25 - 17:25 | Author(s): M. Hendawi
- Abstract
Loading... -
+
18PD_PR - Optimal screening interval for detection of newly developed lung cancer: Comparison of sexual difference
17:25 - 17:25 | Author(s): M.Y. Kim
- Abstract
Loading... -
+
Invited Discussant 17PD and 18PD_PR
17:25 - 17:40 | Author(s): P. Boffetta
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:40 - 17:45
- Abstract
No abstract available for this presentation
